{"id":"https://genegraph.clinicalgenome.org/r/ec460e1e-0024-4310-b4dc-1aea476fd139v1.0","type":"EvidenceStrengthAssertion","dc:description":"There is abundant published evidence associating the SMARCB1 gene with rhabdoid tumor predisposition syndrome 1 (RTPS) since the gene-disease relationship was first proposed by Sevenet et al. (1999). Multiple case level studies have been performed with RTPS patients that have variants in the SMARCB1 gene. SMARCA4, another subunit of the SWI/SNF chromatin remodeling complexes, also cause RTPS. SMARCB1 was absent from neoplastic cells of all tested AT/RTs of RTPS patients in immunohistochemical analysis. Multiple Smarcb1 haploinsufficiency mice models indicate the development of malignant rhabdoid tumors in mice. All of these types of evidence are consistent with a definitive relationship between the SMARCB1 gene and rhabdoid tumor predisposition syndrome 1 (RTPS).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/ec460e1e-0024-4310-b4dc-1aea476fd139","GCISnapshot":"https://genegraph.clinicalgenome.org/r/8d7390e7-0bb1-4ba1-b97e-7f666b52c86b","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/8d7390e7-0bb1-4ba1-b97e-7f666b52c86b_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2018-10-12T20:59:53.762Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/8d7390e7-0bb1-4ba1-b97e-7f666b52c86b_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2020-09-01T00:00:00Z","role":"Publisher"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8d7390e7-0bb1-4ba1-b97e-7f666b52c86b_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8d7390e7-0bb1-4ba1-b97e-7f666b52c86b_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a4551b6a-dcfc-49f0-8fb3-c7d3fdbad3cd","type":"EvidenceLine","dc:description":"The role of Snf5 in development and cancer in a mouse model","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0a03f9ea-0478-40e4-a067-19365be3f630","type":"Finding","dc:description":"Beginning as early as 5 weeks of age, heterozygous mice develop tumors consistent with MRT. The majority of tumors arise in soft tissues derived from the first branchial arch.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11095756","rdfs:label":"Snf5 haploinsufficiency mice show malignant rhabdoid tumors","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/e72c1f56-ed2a-4f3d-bc21-6af3cb13020a","type":"EvidenceLine","dc:description":"Tumors developed from Ini1 +/- mice were rhabdoid, defective for Ini1 protein","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fde65653-5e79-4445-a2f0-9ba2073244e6","type":"Finding","dc:description":"Observation of the cohort of mice for nearly 2 yr revealed the development of spontaneous face and brain tumors, at a very high frequency (\u000126%) (Figs. 2e and 3A), and a small percentage of mice developed tumors in the hind limb. A closer examination revealed the presence of rhabdoid cells in the majority of these tumors (Fig. 3B).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16099835","rdfs:label":"Development of rhabdoid tumors in Ini1 heterozygous mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/8d7390e7-0bb1-4ba1-b97e-7f666b52c86b_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b0481c4d-5ee9-4294-b833-e09f06039ce9","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/12743a52-81fd-4cb6-b9a9-6450744329a5","type":"Finding","dc:description":"SMARCA4 and SMARCB1 are two subunits of the SWI/SNF chromatin remodeling complexes and they physically interact with each other (Figure 1-3 and Figure 6-7). SMARCA4 (MIM 603254) cause Rhabdoid tumor predisposition syndrome 2 (MIM: 613325).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23540691","rdfs:label":"SMARCA4 and SMARCB1 interaction","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e6b2c2cb-b558-4f16-b80f-4e07b56e809c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1548214e-eae1-4cc4-be09-2b14d3941264","type":"Finding","dc:description":"SMARCB1-staining was negative in 39 and not available in nine tumors.  All eight available germline mutation carrying tumors displayed negative SMARCB1-staining.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19902524","rdfs:label":"SMARCB1 staining at immunochemistry","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5356e18a-3a80-4fab-a2a9-6b8bab0adb73","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e69da7ad-5718-4ff4-a5bc-e55f2571ed50","type":"Finding","dc:description":"No INI1 nuclear staining was found in all 20 AT/RTs. Most other central nervous system tumors demonstrated nuclear staining.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15105654","rdfs:label":"Immunohistochemical Analysis of hSNF5/INI1 in CNS Neoplasms","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/3aba1fdc-c686-49d8-a14e-678109419fb3","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5c068f62-c46e-4f1a-b89e-3b795e90eed7","type":"Finding","dc:description":"Immunohistochemical staining of the two AT/RTs as well as the resected schwannomas from III.1 and III.4 confirmed that Smarcb1 was absent from the neoplastic cells of all four tumours (fig 2).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19124645","rdfs:label":"Smarcb1 was absent from neoplastic cells of all four tumors","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/8d7390e7-0bb1-4ba1-b97e-7f666b52c86b_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8d7390e7-0bb1-4ba1-b97e-7f666b52c86b_ad_dn_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/daabb8eb-7765-4265-b8da-9da71e92d381_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A C-T transition resulting in a nonsense mutation at codon 158 (bp 472).  De novo mutaion due to parental mosaicism.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/897c5efb-ba0d-46e5-a772-874b8d530753","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10521299","rdfs:label":"pedigree 2","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":3,"detectionMethod":"Direct sequencing or denaturing high-performance liquid chromatography (dHPLC) analysis of blood and tumor DNA","firstTestingMethod":"PCR","phenotypeFreeText":"ORPHA:99966 ATYPICAL TERATOID RHABDOID TUMOR","phenotypes":"obo:HP_0002885","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/daabb8eb-7765-4265-b8da-9da71e92d381_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10521299","allele":{"id":"https://genegraph.clinicalgenome.org/r/a094d5a2-f218-4bd8-ab39-6927af35d4bb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000022.11:g.23801053C>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA410934530"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/459c3814-5f2e-480b-b7fd-c2b133ff2dba_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A deletion of one G at codon 197 (bp 591), leading to a frameshift. De novo mutation due to maternal mosaicism.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/76173fc5-6996-4893-9c4c-50ad36a61463","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10521299","rdfs:label":"pedigree 3","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":2,"detectionMethod":"Direct sequencing or denaturing high-performance liquid chromatography (dHPLC) analysis of blood and tumor DNA","firstTestingMethod":"PCR","phenotypeFreeText":"ORPHA:99966 Atypical teratoid rhabdoid tumor","phenotypes":"obo:HP_0030392","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/459c3814-5f2e-480b-b7fd-c2b133ff2dba_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10521299","allele":{"id":"https://genegraph.clinicalgenome.org/r/dd6bae91-e7ee-4d62-8c31-3fbd0bd1bd19","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003073.4(SMARCB1):c.591delG (p.Gln198Argfs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/8024"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/52c9f76a-80fc-4b78-ae31-8c190d060990_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A C-T transition results in a nonsense mutation at codon 201 (bp 601). De novo mutation due to paternal mosaicism.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/42bc66b4-b259-4544-b646-9b5a7210030a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10521299","rdfs:label":"pedigree 4","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":5,"detectionMethod":"Direct sequencing or denaturing high-performance liquid chromatography (dHPLC) analysis of blood and tumor DNA","firstTestingMethod":"PCR","phenotypeFreeText":"ORPHA:99966 Atypical teratoid rhabdoid tumor","phenotypes":"obo:HP_0030070","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/52c9f76a-80fc-4b78-ae31-8c190d060990_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10521299","allele":{"id":"https://genegraph.clinicalgenome.org/r/77027312-6156-4a4f-8a67-31932545e5ed","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003073.4(SMARCB1):c.601C>T (p.Arg201Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/532962"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallAutosomalDominantDeNovoVariantEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/8d7390e7-0bb1-4ba1-b97e-7f666b52c86b_ad_null_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4214e87a-a66a-4423-a480-8ea2d0fa89bd_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Early frameshift variant","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/55f648ec-6b14-4f6a-9bc9-631950050f80","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19902524","rdfs:label":"UPN 6","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":5,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"ORPHA:99966 Atypical teratoid rhabdoid tumor","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/4214e87a-a66a-4423-a480-8ea2d0fa89bd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19902524","allele":{"id":"https://genegraph.clinicalgenome.org/r/03d729a3-7023-45fd-998f-6b15bff26239","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003073.4(SMARCB1):c.178_179delAG (p.Arg60Glufs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/486500"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/75da856c-531b-4e53-afbc-6ef7d21c22ce_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A germline splice site mutation of the SMARCB1 gene, leading to exclusion of exon 7 from the mature cDNA and a subsequent frameshift.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1093a9d7-aa07-4118-a677-860b9d0d3414","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10739763","rdfs:label":"Proband","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":18,"detectionMethod":"","firstTestingMethod":"PCR","phenotypeFreeText":"ORPHA:99966 Atypical teratoid rhabdoid tumor","phenotypes":"obo:HP_0030392","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/75da856c-531b-4e53-afbc-6ef7d21c22ce_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10739763","allele":{"id":"https://genegraph.clinicalgenome.org/r/556d99ec-a085-4a41-98d6-1e23ff68c64b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"SMARCB1, IVS7DS, G-A, +1","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/8025"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/2eae6ad1-d221-40f2-9636-14976e2a20e4_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A heterozygous germline 2,631-bp duplication in chromosome 22q11 that included exon 6 of the SMARCB1 gene. The mutation was predicted to result in premature protein termination.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/13b910a0-ad63-4298-9982-1d429f2c7c94","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19124645","rdfs:label":"IV.2","ageType":"AgeAtDeath","ageUnit":"Years","ageValue":2,"detectionMethod":"High resolution array comparative genomic hybridisation (array CGH) using a chromosome 22 specific array with 65 bp median probe spacing.","firstTestingMethod":"High resolution melting","phenotypeFreeText":"ORPHA:99966 Atypical teratoid rhabdoid tumor","phenotypes":"obo:HP_0100008","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"PCR","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/2eae6ad1-d221-40f2-9636-14976e2a20e4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19124645","allele":{"id":"https://genegraph.clinicalgenome.org/r/76e9a894-0ff3-4919-9f69-cfa54d11e446","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003073.4(SMARCB1):c.629-361_795+2103dup","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/8030"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/cc281df7-24d1-409a-96e3-64a8e714fa1e_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A deletion of one G at codon 144 (bp 430), resulting in a frameshift.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/168cf15b-70cf-438f-ab18-5bbd7eb6f0a1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10521299","rdfs:label":"pedigree 1","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":16,"detectionMethod":"Direct sequencing or denaturing high-performance liquid chromatography (dHPLC) analysis of blood and tumor DNA","firstTestingMethod":"PCR","phenotypeFreeText":"ORPHA:99966 Atypical teratoid rhabdoid tumor","phenotypes":"obo:HP_0030392","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/cc281df7-24d1-409a-96e3-64a8e714fa1e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10521299","allele":{"id":"https://genegraph.clinicalgenome.org/r/d192e12e-b0b8-4d2e-843e-d702df9c6c48","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000022.11:g.23801011del","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA513774244"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantNullVariantEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/8d7390e7-0bb1-4ba1-b97e-7f666b52c86b_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b93ef928-5a37-45e8-8442-5df026444ece_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10521299","rdfs:label":"pedigree 2","family":{"id":"https://genegraph.clinicalgenome.org/r/b93ef928-5a37-45e8-8442-5df026444ece","type":"Family","rdfs:label":"pedigree 2","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/897c5efb-ba0d-46e5-a772-874b8d530753"}},"phenotypeFreeText":"ORPHA:99966 ATYPICAL TERATOID RHABDOID TUMOR","phenotypePositiveAllelePositive":2,"phenotypes":"obo:HP_0002885","proband":{"id":"https://genegraph.clinicalgenome.org/r/897c5efb-ba0d-46e5-a772-874b8d530753"}},{"id":"https://genegraph.clinicalgenome.org/r/7b25d64b-7349-4d6c-ba0d-4808a2f43df8_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10521299","rdfs:label":"pedigree 4","family":{"id":"https://genegraph.clinicalgenome.org/r/7b25d64b-7349-4d6c-ba0d-4808a2f43df8","type":"Family","rdfs:label":"pedigree 4","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/42bc66b4-b259-4544-b646-9b5a7210030a"}},"phenotypeFreeText":"ORPHA:99966 Atypical teratoid rhabdoid tumor","phenotypePositiveAllelePositive":1,"phenotypes":"obo:HP_0030070","proband":{"id":"https://genegraph.clinicalgenome.org/r/42bc66b4-b259-4544-b646-9b5a7210030a"}},{"id":"https://genegraph.clinicalgenome.org/r/766317b8-6dfb-42ee-830f-48531f7a4f21_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10739763","rdfs:label":"Pedigree","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/766317b8-6dfb-42ee-830f-48531f7a4f21","type":"Family","rdfs:label":"Pedigree","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/1093a9d7-aa07-4118-a677-860b9d0d3414"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"ORPHA:99966 Atypical teratoid rhabdoid tumor","phenotypePositiveAllelePositive":2,"phenotypes":"obo:HP_0030392","proband":{"id":"https://genegraph.clinicalgenome.org/r/1093a9d7-aa07-4118-a677-860b9d0d3414"}},{"id":"https://genegraph.clinicalgenome.org/r/56e03edb-a481-42dd-90ea-d93d3059fbdf_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10521299","rdfs:label":"pedigree 1","family":{"id":"https://genegraph.clinicalgenome.org/r/56e03edb-a481-42dd-90ea-d93d3059fbdf","type":"Family","rdfs:label":"pedigree 1","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/168cf15b-70cf-438f-ab18-5bbd7eb6f0a1"}},"phenotypeFreeText":"ORPHA:99966 Atypical teratoid rhabdoid tumor","phenotypePositiveAllelePositive":2,"phenotypes":"obo:HP_0030392","proband":{"id":"https://genegraph.clinicalgenome.org/r/168cf15b-70cf-438f-ab18-5bbd7eb6f0a1"}},{"id":"https://genegraph.clinicalgenome.org/r/6a056346-6af9-4d70-ac68-19815de3bf42_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10521299","rdfs:label":"pedigree 3","family":{"id":"https://genegraph.clinicalgenome.org/r/6a056346-6af9-4d70-ac68-19815de3bf42","type":"Family","rdfs:label":"pedigree 3","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/76173fc5-6996-4893-9c4c-50ad36a61463"}},"phenotypeFreeText":"ORPHA:99966 Atypical teratoid rhabdoid tumor","phenotypePositiveAllelePositive":3,"phenotypes":"obo:HP_0030392","proband":{"id":"https://genegraph.clinicalgenome.org/r/76173fc5-6996-4893-9c4c-50ad36a61463"}},{"id":"https://genegraph.clinicalgenome.org/r/842495d6-f0ec-465a-a2e9-5bd07e4e3d91_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19124645","rdfs:label":"family K18853","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/842495d6-f0ec-465a-a2e9-5bd07e4e3d91","type":"Family","rdfs:label":"family K18853","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/13b910a0-ad63-4298-9982-1d429f2c7c94"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"ORPHA:99966 Atypical teratoid rhabdoid tumor","phenotypePositiveAllelePositive":7,"phenotypes":"obo:HP_0100008","proband":{"id":"https://genegraph.clinicalgenome.org/r/13b910a0-ad63-4298-9982-1d429f2c7c94"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":625,"specifiedBy":"GeneValidityCriteria6","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/FRTI4ni-5no","type":"GeneValidityProposition","disease":"obo:MONDO_0012252","gene":"hgnc:11103","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_8d7390e7-0bb1-4ba1-b97e-7f666b52c86b-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}